Literature DB >> 16049071

Left ventricular morphology and function in patients with atherosclerotic renovascular disease.

Julian R Wright1, Ala'a E Shurrab, Anne Cooper, Paul R Kalra, Robert N Foley, Philip A Kalra.   

Abstract

Atherosclerotic renovascular disease (ARVD) is associated with heart disease. There has been no systematic study of cardiac structure and function in patients with this condition. In this study, the epidemiology of cardiac changes and their relationship to renal function, renovascular anatomy, and BP are delineated. With the use of a cross-sectional design, 79 patients with ARVD and 50 control patients without ARVD underwent echocardiography and 24-h ambulatory BP monitoring. Clinical and biochemical data were collected. Results were analyzed according to renal function, residual renal artery patency, and unilateral or bilateral ARVD. Only 4 (5.1%) patients with ARVD had normal cardiac structure and function. Patients with ARVD (age 70.7 +/- 7.5 yr; estimated GFR 36 +/- 19 ml/min) had significantly more cardiovascular comorbidity (77.2 versus 42.0%; P < 0.001), greater prevalence of left ventricular (LV) hypertrophy (78.5 versus 46.0%; P < 0.001) and LV diastolic dysfunction (74.6 versus 40.0%; P < 0.001), and greater LV mass index (183 +/- 74 versus 116 +/- 33 g/m2; P < 0.001) and LV end-diastolic volume index (82 +/- 35 versus 34 +/- 16 ml/m2; P < 0.001) than control subjects. BP was similar for both patient groups. For patients with ARVD, neither renal function nor renal artery patency predicted a difference in echocardiographic or ambulatory BP monitoring parameters. Patients with bilateral ARVD had greater LV mass index and LV dilation than patients with unilateral disease. Patients with ARVD exhibit a high prevalence of cardiac morphologic and functional abnormalities at early stages of renal dysfunction. Such patients must be identified early in their disease course to allow risk factor modification.

Entities:  

Mesh:

Year:  2005        PMID: 16049071     DOI: 10.1681/ASN.2005010043

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease.

Authors:  Hao-jian Dong; Cheng Huang; De-mou Luo; Jing-guang Ye; Jun-qing Yang; Guang Li; Jian-fang Luo; Ying-ling Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

2.  Prevalence of renal artery stenosis in patients undergoing cardiac catheterization.

Authors:  Carmelita Marcantoni; Marcantoni Carmelita; Stefania Rastelli; Rastelli Stefania; Luca Zanoli; Zanoli Luca; Giovanni Tripepi; Tripepi Giovanni; Marilena Di Salvo; Di Salvo Marilena; Sergio Monaco; Monaco Sergio; Carmelo Sgroi; Sgroi Carmelo; Davide Capodanno; Capodanno Davide; Corrado Tamburino; Tamburino Corrado; Pietro Castellino; Castellino Pietro
Journal:  Intern Emerg Med       Date:  2011-05-25       Impact factor: 3.397

3.  Diastolic function predicts survival after renal revascularization.

Authors:  Racheed J Ghanami; Hamza Rana; Timothy E Craven; John Hoyle; Matthew S Edwards; Kimberley J Hansen
Journal:  J Vasc Surg       Date:  2011-08-06       Impact factor: 4.268

4.  [Medicinal or instrumental (corrected) therapy of renal artery stenosis?].

Authors:  L C Rump; L Sellin
Journal:  Internist (Berl)       Date:  2012-06       Impact factor: 0.743

Review 5.  Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure.

Authors:  Branko Braam; William A Cupples; Jaap A Joles; Carlo Gaillard
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

6.  Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Behzad Ebrahimi; James D Krier; Scott M Riester; Andre J van Wijnen; Amir Lerman; Lilach O Lerman
Journal:  Cell Transplant       Date:  2014-11-21       Impact factor: 4.064

Review 7.  Blockade of the renin-angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.

Authors:  Faical Jarraya; Menno Pruijm; Gregoire Wuerzner; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 8.  Atherosclerotic renovascular disease and renal impairment: can we predict the effect of intervention?

Authors:  Kwok-Wai Mui; Arend-Jan Woittiez; Gerjan Navis
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 5.369

9.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction.

Authors:  Kirandeep K Khangura; Alfonso Eirin; Garvan C Kane; Sanjay Misra; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2013-10-25       Impact factor: 2.689

10.  Predictors of cardiac benefits of renal artery stenting from a multicentre retrospective registry.

Authors:  Yuri Nakajima; Osami Kawarada; Akihiro Higashimori; Yoshiaki Yokoi; Kan Zen; Hitoshi Anzai; Hideki Doi; Seiji Hokimoto; Shigenori Ito; Taku Kato; Teruyoshi Kume; Yoshiaki Shintani; Shuzou Tanimoto; Yoshinori Tsubakimoto; Makoto Utsunomiya; Kunihiro Nishimura; Satoshi Yasuda
Journal:  Heart Asia       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.